Fetal viability is the point at which a fetus can potentially survive outside the uterus, typically with intensive medical support. There is no single gestational age that marks a hard line. Instead, viability exists on a spectrum, with survival chances rising steeply between about 22 and 26 weeks of pregnancy. The concept carries weight in both medical decision-making and law, but in practice, it comes down to individual circumstances rather than a fixed number on a calendar.
Why There’s No Single Definition
The American College of Obstetricians and Gynecologists notes there is no single formally recognized clinical definition of viability, and no test that can definitively determine whether a fetus could survive outside the uterus. In early pregnancy, doctors use the word “viable” simply to mean a pregnancy is developing normally, based on ultrasound and hormone levels. Later in pregnancy, the term shifts to mean something different: whether a baby born at that point could survive.
That second meaning is the one most people are asking about, and it depends on far more than gestational age alone. A baby’s weight, biological sex, genetic factors, the circumstances of delivery, and whether a hospital has a specialized neonatal intensive care team all influence the outcome. Two babies born at the same gestational age can have very different chances of survival depending on these variables.
The Periviable Period: Weeks 22 Through 25
Doctors focus on a window called the periviable period, spanning 20 weeks through 25 weeks and 6 days of gestation. This is where survival transitions from nearly impossible to increasingly likely, though still uncertain. The most recent data from the American Academy of Pediatrics, covering 2020 to 2022, gives a clearer picture of what these odds look like week by week:
- 22 weeks: About 25% of all infants survived. Among those who received active life support (68% did), survival rose to 35.4%.
- 23 weeks: About 53% survived overall. Life support was provided in 95% of cases.
- 24 weeks: About 71% survived. Nearly all (99%) received life support.
- 25 weeks: About 82% survived, and virtually all received life support.
Before 23 weeks, survival drops to roughly 5 to 6%, and among those rare survivors, serious complications are nearly universal. Each additional week in the womb at this stage dramatically shifts the odds.
What Makes Survival Possible
The biggest biological barrier to survival at very early gestational ages is the lungs. A fetus’s lungs produce a substance called surfactant, which coats the tiny air sacs and keeps them from collapsing every time the baby exhales. The cells that make surfactant begin to develop between 24 and 34 weeks. Before that window, the lungs simply aren’t equipped to handle breathing air, even with help.
This is why babies born before 24 weeks need aggressive respiratory support. Neonatal intensive care units use specialized ventilators, including high-frequency oscillatory ventilation, continuous positive airway pressure machines, and carefully controlled incubators that regulate temperature and reduce infection risk. Every time staff open an incubator to adjust a sensor or reposition a monitor, the baby loses body heat and faces increased exposure to germs. The technology is extraordinary, but it has limits.
One intervention that significantly shifts survival odds happens before delivery. Giving the pregnant person a course of corticosteroids helps speed up lung maturation in the fetus. A large review of over 2,200 infants born at 22 weeks found that survival doubled when corticosteroids were given beforehand: 39% compared to 19.5% without them. However, survival without a major complication remained very low at 4.4%, underscoring how precarious outcomes still are at that gestational age.
Factors Beyond Gestational Age
Gestational age gets the most attention, but it’s one variable among several. Birth weight matters considerably. Babies who are small for their gestational age face worse odds than those who have grown on track. Biological sex also plays a measurable role. A systematic review of studies on premature and low-birth-weight infants found that 26 out of 32 studies showed higher mortality in males compared to females at the same gestational age. This “male disadvantage” is well documented in neonatal medicine and can influence clinical discussions about prognosis.
Where the birth happens also matters. Guidelines from ACOG and the Society for Maternal-Fetal Medicine recommend that periviable births, when intervention is planned, should occur at centers with specialized maternal and neonatal care teams and the infrastructure to support them. A baby born at 23 weeks in a hospital with a Level IV NICU and experienced neonatologists has meaningfully better prospects than the same baby born at a community hospital without those resources.
Survival Isn’t the Whole Picture
Surviving the NICU is one milestone, but long-term health is another question entirely. Among infants born at 22 weeks who received life support in the 2020-2022 data, only 6.3% survived without severe complications. At 25 weeks, that number improved to 43.2%, which still means more than half of survivors at that age experienced at least one serious complication.
A Swedish study that followed extremely preterm children (born before 27 weeks) to age 6.5 found that about one-third had moderate to severe neurodevelopmental disabilities. That included roughly 20% with moderate disability and 13% with severe disability. The remaining two-thirds had mild or no disability, which is encouraging, but the rates of significant challenges are high enough that they factor heavily into conversations between parents and medical teams about what to expect.
Viability in the Legal Sense
Outside the hospital, viability carries legal significance. In the United States, 18 states set their gestational limits for abortion at or near the point of viability, generally presumed to be around 24 weeks. But courts have never precisely defined viability, and the legal standard acknowledges that it varies by individual pregnancy. The gap between a legal threshold and a clinical reality is real: a 24-week legal cutoff suggests a clear line, while the medical picture is a gradient where probability shifts week by week, baby by baby.
This disconnect matters because viability is not a fixed biological event. It is shaped by the technology available, the expertise of the care team, and the specific characteristics of each pregnancy. What was not viable 30 years ago may be viable today at a top-tier hospital, and what is viable at one facility may not be at another across town.